CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2017

Nov 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2017-11-09

Reporting Person: Tierney David S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-09	Common stock, par value $0.001 per share	M	50000	$0.47	Acquired	313401	Direct
2017-11-09	Common stock, par value $0.001 per share	F	7860	—	Disposed	305541	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-11-09	Options to purchase common stock	$0.47	M	50000	Disposed	2017-12-12	Common Stock (50000)	Direct

Footnotes

F1: Holder exercised 50,000 options at $0.47 per share via cashless exercise and was issued 42,140 shares based on the November 8, 2017 closing price of $2.99 per share.